Specific Antibody Deficiency

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-05-31
Clinical Trial Update: Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older [NA]
A terminated clinical trial evaluated the immunogenicity of Zostavax in adults aged 60 and older with antibody deficiency conditions.